Glaukos clinical trials we track

Check company identity source

Phase 3 5 trials

Phase 2 11 trials

TrialDrugs studiedStatusPrimary completion
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718Gen 2 Travoprost Intracameral Implant, Sham Procedure, Timolol eye drops 0.5%Recruiting2028-03Estimated
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusNCT07400952GLK-221 Ophthalmic SolutionRecruiting2027-04Estimated
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisNCT07400965GLK-321 high dose BID, GLK-321 high dose QD, GLK-321 low dose BID, GLK-321 mid dose BIDRecruiting2026-09Estimated
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Vehicle, lufepirsen high dose, lufepirsen low doseRecruiting2025-12Estimated
Performance of the Travoprost Intraocular ImplantNCT06582732Travoprost Intracameral Implant exchanged at Month 12, Travoprost Intracameral Implant exchanged at Month 24, Travoprost Intracameral Implant exchanged at Month 3, Travoprost Intracameral Implant exchanged at Month 6 and 3 moreCompleted2023-11-02Actual
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaNCT05124275Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine Ophthalmic Topical Cream, Dose 2, Pilocarpine Ophthalmic Topical Cream, Dose 3Completed2022-09-06Actual
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseNCT05119920Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine Ophthalmic Topical Cream, Dose 2, Pilocarpine Ophthalmic Topical Cream, Dose 3Completed2022-07-27Actual
Study of Exchange of Travoprost Intraocular ImplantNCT04615403TravoprostCompleted2022-02-28Actual
Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionNCT02754596Timolol Maleate Ophthalmic Solution, 0.5%, Travoprost Intraocular Implant, high elution, Travoprost Intraocular Implant, low elutionCompleted2017-08-01Actual
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesNCT04081103Nexagon® (lufepirsen) High Dose Concentration, Nexagon® (lufepirsen) Low Dose Concentration, Open-label Nexagon® (lufepirsen), VehicleTerminated2022-02-07Actual
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionNCT06152861Timolol maleate ophthalmic solution, 0.5%, Travoprost Ophthalmic Solution, 0.004%, Travoprost Ophthalmic Topical Cream high-dose, Travoprost Ophthalmic Topical Cream low-dose and 1 moreUnknown2024-08Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters